Mitochondrial Diseases D028361

Diseases [C] » Nutritional and Metabolic Diseases [C18] » Metabolic Diseases » Mitochondrial Diseases

Description

Diseases caused by abnormal function of the MITOCHONDRIA. They may be caused by mutations, acquired or inherited, in mitochondrial DNA or in nuclear genes that code for mitochondrial components. They may also be the result of acquired mitochondria dysfunction due to adverse effects of drugs, infections, or other environmental causes.   MeSH

Hierarchy View

Subtype Terms (10)

Carbamoyl-Phosphate Synthase I Deficiency Disease
1 approved drug

Cytochrome-c Oxidase Deficiency
 

Friedreich Ataxia
35 drugs (18 approved, 17 experimental)

Leigh Disease
3 drugs (1 approved, 2 experimental)

Mitochondrial Myopathies
10 drugs (4 approved, 6 experimental)

Multiple Acyl Coenzyme A Dehydrogenase Deficiency
1 experimental drug

Optic Atrophy, Autosomal Dominant
 

Optic Atrophy, Hereditary, Leber
18 drugs (2 approved, 16 experimental)

Pyruvate Carboxylase Deficiency Disease
2 drugs (1 approved, 1 experimental)

Pyruvate Dehydrogenase Complex Deficiency Disease
2 drugs (1 approved, 1 experimental)


Approved Indicated Drugs (1)

Phase 3 Indicated Drugs (3)


Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.